Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability

OBJECTIVES: Mortality associated with sickle cell disease (SCD) is high in many low- and middle-income countries (LMICs). Hydroxyurea, a medicine to effectively manage SCD, is not widely available in resource-constrained settings. We identified and synthesised the reported implementation outcomes fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Nessa, Dike, Lotanna, Ojo, Temitope, Vieira, Dorice, Nnodu, Obiageli, Gyamfi, Joyce, Peprah, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654121/
https://www.ncbi.nlm.nih.gov/pubmed/33168553
http://dx.doi.org/10.1136/bmjopen-2020-038685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654121/
https://www.ncbi.nlm.nih.gov/pubmed/33168553
http://dx.doi.org/10.1136/bmjopen-2020-038685

Ejemplares similares